Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dual therapy based on co-formulated darunavir/ritonavir plus lamivudine for initial therapy of HIV infection: The ANDES randomized controlled trial.
Figueroa MI, Sued O, Cecchini D, Sanchez M, Rolón MJ, Lopardo G, Ceschel M, Mernies G, De Stefano M, Patterson P, Gun A, Fink V, Ortiz Z, Cahn P; ANDES Study Group. Figueroa MI, et al. Among authors: fink v. Int J Antimicrob Agents. 2024 Oct;64(4):107301. doi: 10.1016/j.ijantimicag.2024.107301. Epub 2024 Aug 14. Int J Antimicrob Agents. 2024. PMID: 39151647 Clinical Trial.
Use of darunavir and enfuvirtide in a pregnant woman.
Sued O, Lattner J, Gun A, Patterson P, Abusamra L, Cesar C, Fink V, Krolewiecki A, Cahn P. Sued O, et al. Among authors: fink v. Int J STD AIDS. 2008 Dec;19(12):866-7. doi: 10.1258/ijsa.2008.008075. Int J STD AIDS. 2008. PMID: 19050223
Fostemsavir: a new CD4 attachment inhibitor.
Cahn P, Fink V, Patterson P. Cahn P, et al. Among authors: fink v. Curr Opin HIV AIDS. 2018 Jul;13(4):341-345. doi: 10.1097/COH.0000000000000469. Curr Opin HIV AIDS. 2018. PMID: 29771694 Review.
The effect of protease inhibitor-based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART-naïve patients with HIV-infection.
Figueroa MI, Camiro-Zuñiga A, Belaunzaran-Zamudio PF, Sierra Madero J, Andrade Villanueva J, Arribas JR, Lama JR, Cecchini DM, Lopardo G, Crabtree-Ramírez B, Gun A, Patterson P, Fink VI, Sued OG, Cahn P. Figueroa MI, et al. Among authors: fink vi. HIV Med. 2021 Apr;22(4):254-261. doi: 10.1111/hiv.13008. Epub 2020 Dec 17. HIV Med. 2021. PMID: 33336523 Free article.
Retention among transgender women treated with dolutegravir associated with tenofovir/lamivudine or emtricitabine in Argentina: TransViiV study.
Frola CE, Aristegui I, Figueroa MI, Radusky PD, Cardozo N, Zalazar V, Cesar C, Patterson P, Fink V, Gun A, Cahn P, Sued O. Frola CE, et al. Among authors: fink v. PLoS One. 2023 Jan 20;18(1):e0279996. doi: 10.1371/journal.pone.0279996. eCollection 2023. PLoS One. 2023. PMID: 36662723 Free PMC article. Clinical Trial.
Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters.
Socías ME, Sued O, Laufer N, Lázaro ME, Mingrone H, Pryluka D, Remondegui C, Figueroa MI, Cesar C, Gun A, Turk G, Bouzas MB, Kavasery R, Krolewiecki A, Pérez H, Salomón H, Cahn P; Grupo Argentino de Seroconversión Study Group. Socías ME, et al. J Int AIDS Soc. 2011 Aug 10;14:40. doi: 10.1186/1758-2652-14-40. J Int AIDS Soc. 2011. PMID: 21831310 Free PMC article.
Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study.
Cesar C, Jenkins CA, Shepherd BE, Padgett D, Mejía F, Ribeiro SR, Cortes CP, Pape JW, Madero JS, Fink V, Sued O, McGowan C, Cahn P; Caribbean, Central and South America Network for HIV Epidemiology (CCASAnet) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Program. Cesar C, et al. Among authors: fink v. Lancet HIV. 2015 Nov;2(11):e492-500. doi: 10.1016/S2352-3018(15)00183-6. Epub 2015 Oct 22. Lancet HIV. 2015. PMID: 26520929 Free PMC article.
85 results